Semler to Report Fourth Quarter and Year End 2021 Financial Results and Host Conference Call on February 28, 2022
Semler Scientific (Nasdaq: SMLR) will report its fourth quarter and full year financial results for 2021 on February 28, 2022, after U.S. market close. A conference call hosted by CEO Doug Murphy-Chutorian will occur at 4:30 PM ET the same day, featuring senior executives Andrew Weinstein and Dennis Rosenberg. Participants can pre-register for the call to receive a passcode for immediate access. Semler Scientific specializes in technology solutions for healthcare and offers the FDA-cleared QuantaFlo®, a test to evaluate risks of chronic diseases.
- Upcoming financial report may indicate strong performance metrics.
- QuantaFlo® offers a unique FDA-cleared technology for assessing peripheral arterial disease.
- None.
SANTA CLARA, Calif., Feb. 17, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2021, after the close of U.S. financial markets on Monday, February 28, 2022. Doug Murphy-Chutorian, M.D., chief executive officer of Semler Scientific, will host a conference call at 4:30 pm ET the same day. Andrew Weinstein, senior vice president, finance and accounting, and Dennis Rosenberg, chief marketing officer, will join him on the call.
We encourage participants to pre-register for the conference call using the following link: https://dpregister.com/sreg/10163929/f18044ea2b. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.
Those without internet access or unable to pre-register may dial in by calling:
Domestic callers: 866-777-2509
International callers: 412-317-5413
Please specify to the operator that you would like to join the "Semler Scientific Call." The conference call will be archived on Semler Scientific's website at www.semlerscientific.com.
About Semler Scientific, Inc.:
Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific's mission is to develop, manufacture and market innovative products and services that assist its customers in evaluating and treating chronic diseases. Semler Scientific's patented and U.S. Food and Drug Administration, or FDA, cleared product, QuantaFlo®, is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. QuantaFlo® is used by Semler Scientific's customers to more comprehensively evaluate their patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care. Additional information about Semler Scientific can be found at www.semlerscientific.com.
CONTACT:
Susan A. Noonan
S.A. Noonan Communications
susan@sanoonan.com
212 966 3650
View original content:https://www.prnewswire.com/news-releases/semler-to-report-fourth-quarter-and-year-end-2021-financial-results-and-host-conference-call-on-february-28-2022-301484601.html
SOURCE Semler Scientific, Inc.
FAQ
When will Semler Scientific report its fourth quarter results for 2021?
What is the significance of the QuantaFlo® product for Semler Scientific?
Who will participate in the Semler Scientific conference call?
How can I join the Semler Scientific conference call?
